JPRN-UMIN000015282招募中未知
vitreous surgery with intravitreal tissue plasminogen activator(t-PA) - vitreous surgery with intravitreal t-PA
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with drug allergy for t-PA Pregnancy
研究者
相似试验
已完成
不适用
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20
招募中
不适用
Pars plana vitrectomy with scleral imbrication for myopic schisismyopic schisisJPRN-UMIN000017143Chiba University Graduate School of Medicine15
已完成
不适用
Vitrectomy combined with intravitreal triamcinolone acetonide injection for diabetic macular edemaDiabetic macular edemaJPRN-UMIN000017250Tohoku University Graduate School of Medicine60
进行中（未招募）
1 期
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER).Exudative age-related macular degenerationMedDRA version: 20.0Level: LLTClassification code: 10075718Term: Exudative age-related macular degeneration Class: 10015919CTIS2023-504751-28-00King's College London90
进行中（未招募）
1 期
A study of surgery to clear bleeding due to age-related macular degeneration.EUCTR2020-004917-10-DEKing's College London210